Position in RDY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$586,149
-$22,184 QoQ
Shares Held
40,452
-7.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#14
of 58 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RDY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Atria Investments, Inc holds $17,433,997 across 16 Drug Manufacturers - Specialty & Generic names. RDY ranks #11 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
41,255 | $2,964,584 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
107,060 | $2,634,746 | |
| 3 | VTRS |
Viatris Inc
|
162,893 | $2,586,740 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
12,667 | $2,134,896 | |
| 5 | HLN |
Haleon plc
|
178,931 | $1,669,426 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
39,602 | $1,341,715 | |
| 7 | PBH |
Prestige Consumer Healthcare Inc.
|
17,098 | $808,222 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
42,964 | $688,712 |
All Filings in RDY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $586,149 | 40,452 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $608,333 | 43,923 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $559,634 | 39,860 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $572,411 | 40,945 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $491,976 | 32,733 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $140,882 | 10,681 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $170,089 | 10,772 | Shares | Sole | 2025-02-06 | |
| 2024-06-30 | $354,435 | 4,652 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||